![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/437 | (2006.01) |
A61K 45/06 | (2006.01) | ||
A61K 31/08 | (2006.01) | ||
A61K 31/352 | (2006.01) | ||
A61K 31/4164 | (2006.01) | ||
A61K 31/426 | (2006.01) | ||
A61K 31/4439 | (2006.01) | ||
A61K 31/606 | (2006.01) | ||
A61K 31/7016 | (2006.01) | ||
A61K 31/785 | (2006.01) | ||
A61K 38/14 | (2006.01) | ||
A61K 38/31 | (2006.01) | ||
A61P 1/16 | (2006.01) | ||
A61K 31/395 | (2006.01) |
(11) | Number of the document | 3628319 |
(13) | Kind of document | T |
(96) | European patent application number | 19207534.9 |
Date of filing the European patent application | 2009-10-02 | |
(97) | Date of publication of the European application | 2020-04-01 |
(45) | Date of publication and mention of the grant of the patent | 2024-02-14 |
(46) | Date of publication of the claims translation | 2024-03-25 |
(30) | Number | Date | Country code |
102349 P | 2008-10-02 | US |
(72) |
FORBES, William , US
|
(73) |
Salix Pharmaceuticals, Inc. ,
8450 Colonnade Center Drive, Colonnade 1, Raleigh, NC 27615,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Hepatinės encefalopatijos gydymas rifaksiminu |
TREATMENT OF HEPATIC ENCEPHALOPATHY USING RIFAXIMIN |
Payment date | Validity (years) | Amount | |
2024-08-23 | 16 | 347.00 EUR |
2025-10-02 |